Earlier, the officials had stated that the government may well also use its Civil Lines centre for the storage of the vaccine.
In view of the Drug Controller General of India (DCGI) approving the use of two Coronavirus vaccines in the nation, the work for laying the infrastructure for the world’s biggest vaccination programme has picked up pace in a variety of components of the nation. The Rajiv Gandhi Super Speciality Hospital (RGSSH) in the national capital has been turned into the very first Covid-19 vaccine storage facility and it is prepared to undertake the storage of the very first consignment of vaccines, The Indian Express reported.
By Monday, the facility had completed the setup of all the gear needed for the storage of the vaccine. RGSSH, which is situated in Delhi’s Dilshad Garden location in East Delhi, is one particular of the city’s greatest hospitals with a capacity of 650 beds.
In consonance with the parameters set for sufficient storage of the vaccine, the hospital has installed a total of 40 refrigerators and freezers to preserve the vaccines at an optimum temperature among 2 and 8 degree Celsius. Dr. Chhavi Gupta, media spokesperson at RGSSH, told The Indian Express that the work from the hospital’s finish has been completed and the hospital is now waiting for the very first consignment of the vaccine. Senior Delhi government officials told The Indian Express that the government is preparing to preserve the complete stock of vaccine at RGSSH. Earlier, the officials had stated that the government may well also use its Civil Lines centre for the storage of the vaccine.
Dr. Sunila Garg, director and professor of the division of neighborhood medicine at Maulana Azad Medical College, told The Indian Express that the storage capacity at RGSSH is more than sufficient and the Civil Lines storage centre will not be necessary. RGSSH in all probability will therefore act as the centre of the vaccination drive and the vaccines will be transported from the facility to more than 603 cold chain points identified in the city which will act as the vaccination centres.
On Sunday, the DCGI gave its go-ahead to two Coronavirus vaccine candidates –Oxford University-AstraZeneca’s vaccine manufactured by the Serum Institute and the indigenous Covid-19 vaccine created by Hyderabad primarily based Bharat Biotech in cooperation with the Indian Council of Medical Research (ICMR)—for restricted emergency use approval against the Covid-19 in the nation.